Alcohol consumption linked to increased risk of cancer

alocholA new study, published in the Lancet, has revealed that is linked to an increased of alcohol-related . is proposed to be the third most important modifiable factor for death and disability.

However, has been associated with both benefits and harms, and previous studies were mostly done in high-income countries.

The consisted of 114 970 adults, of whom 12 904 (11%) were from HICs, 24 408 (21%) were from UMICs, 48 845 (43%) were from LMICs, and 28 813 (25%) were from LICs.

Current drinking was reported by 36 030 (31%) individuals. The data came from 12 countries participating in the Prospective Urban Rural Epidemiological (PURE) study, a prospective cohort study of individuals aged 35-70 years.

The high-income countries (HICs) were Sweden and Canada; upper-middle-income countries (UMICs) were Argentina, Brazil, Chile, Poland, , and Turkey; lower-middle-income countries (LMICs) were China and Colombia; and LICs were India and Zimbabwe.

“More than sufficient evidence is available for governments to give increased priority to reducing alcohol-related disease burden in low-income and middle-income countries. This should be done by implementing the most effective population policies to discourage harmful drinking – namely, increasing the price of alcohol and reducing its availability, especially to younger drinkers, and preventing the alcohol from promotion of frequent drinking to intoxication”, said Dr Jason Connor of the Centre for Youth Substance Abuse , University of Queensland, and Professor Wayne Hall of the Centre for Youth Substance Abuse , University of Queensland, Brisbane, QLD, Australia and National Addiction Centre, Kings College London, UK.

Source

and , , injury, admission to hospital, and mortality: a prospective cohort study, Dr Andrew Smyth, PhD, Prof Koon K Teo, PhD, Sumathy Rangarajan, MSc, Martin O’Donnell, PhD, Xiaohe Zhang, MSc, Punam Rana, MD, Darryl P Leong, PhD, Prof Gilles Dagenais, MD, Pamela Seron, MSc, Prof Annika Rosengren, PhD, Prof Aletta E Schutte, PhD, Prof Patricio Lopez-Jaramillo, PhD, Prof Ayetkin Oguz, MD, Jephat Chifamba, MPhil, Rafael Diaz, MD, Prof Scott Lear, PhD, Alvaro Avezum, PhD, Rajesh Kumar, MD, Viswanathan Mohan, MD, Prof Andrzej Szuba, PhD, Li Wei, PhD, Wang Yang, MD, Bo Jian, BSc, Prof Martin McKee, DSc, Prof Salim Yusuf, DPhil on behalf of the PURE Investigators, The Lancet, doi: 10.1016/S0140-6736(15)00235-4, published online 16 September 2015.

Be Sociable, Share!

    Leave a Reply

    Your email address will not be published. Required fields are marked *